SEC Comment Letter for BNB PLUS CORP. (BNBX) (CIK 0000744452) (BNBX) — Sep 23, 2019
BNB PLUS CORP. (BNBX) (CIK 0000744452)
Date: Sept. 23, 2019 · CIK: 0000744452 · Accession: 0000000000-19-013843
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233830
Letter
September 23, 2019 James A. Hayward Chairman, Chief Executive Officer and President Applied DNA Sciences, Inc. 50 Health Sciences Drive Stony Brook, New York 11790 Re:Applied DNA Sciences, Inc. Registration Statement on Form S-1 Filed September 18, 2019 File No. 333-233830 Dear Mr. Hayward: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Gregory Dundas, Attorney Adviser, at (202) 551-3436 with any questions. Sincerely, Division of Corporation Finance Office of Telecommunications cc: Merrill M. Kraines, Esq.
Show Raw Text
September 23, 2019
James A. Hayward
Chairman, Chief Executive Officer and President
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
Re:Applied DNA Sciences, Inc.
Registration Statement on Form S-1
Filed September 18, 2019
File No. 333-233830
Dear Mr. Hayward:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Gregory Dundas, Attorney Adviser, at (202) 551-3436 with any questions.
Sincerely,
Division of Corporation Finance
Office of Telecommunications
cc: Merrill M. Kraines, Esq.